File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Treatment intensification with Dipeptidylpeptidase-4 inhibitor, insulin, or Thiazolidinediones and risks of cardiovascular diseases and all-cause mortality in patients on metformin-sulfonylurea dual therapy
Title | Treatment intensification with Dipeptidylpeptidase-4 inhibitor, insulin, or Thiazolidinediones and risks of cardiovascular diseases and all-cause mortality in patients on metformin-sulfonylurea dual therapy |
---|---|
Authors | |
Issue Date | 2019 |
Citation | 14th International Symposium on Healthy Aging: Embrace the Golden Years, Hong Kong, 16-17 March 2019
How to Cite? |
Abstract | Young Investigator Award Forum II (Oral Category) |
Description | Organized by the Research Centre of Heart, Brain, Hormone and Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong Kong |
Persistent Identifier | http://hdl.handle.net/10722/269379 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shi, YM | - |
dc.contributor.author | Wong, CKH | - |
dc.contributor.author | Man, KCK | - |
dc.contributor.author | Chan, EW | - |
dc.contributor.author | Ho, CW | - |
dc.contributor.author | Tse, TYE | - |
dc.contributor.author | Wong, ICK | - |
dc.contributor.author | Lam, CLK | - |
dc.date.accessioned | 2019-04-24T08:06:29Z | - |
dc.date.available | 2019-04-24T08:06:29Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | 14th International Symposium on Healthy Aging: Embrace the Golden Years, Hong Kong, 16-17 March 2019 | - |
dc.identifier.uri | http://hdl.handle.net/10722/269379 | - |
dc.description | Organized by the Research Centre of Heart, Brain, Hormone and Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong Kong | - |
dc.description.abstract | Young Investigator Award Forum II (Oral Category) | - |
dc.language | eng | - |
dc.relation.ispartof | 14th International Symposium on Healthy Aging, 2019 | - |
dc.title | Treatment intensification with Dipeptidylpeptidase-4 inhibitor, insulin, or Thiazolidinediones and risks of cardiovascular diseases and all-cause mortality in patients on metformin-sulfonylurea dual therapy | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Shi, YM: yrshi@hku.hk | - |
dc.identifier.email | Wong, CKH: carlosho@hku.hk | - |
dc.identifier.email | Man, KCK: mkckth@hku.hk | - |
dc.identifier.email | Chan, EW: ewchan@hku.hk | - |
dc.identifier.email | Ho, CW: hochuwa@hku.hk | - |
dc.identifier.email | Tse, TYE: emilyht@hku.hk | - |
dc.identifier.email | Wong, ICK: wongick@hku.hk | - |
dc.identifier.email | Lam, CLK: clklam@hku.hk | - |
dc.identifier.authority | Wong, CKH=rp01931 | - |
dc.identifier.authority | Chan, EW=rp01587 | - |
dc.identifier.authority | Tse, TYE=rp02382 | - |
dc.identifier.authority | Wong, ICK=rp01480 | - |
dc.identifier.authority | Lam, CLK=rp00350 | - |
dc.identifier.hkuros | 297381 | - |